Intas Pharmaceuticals Launches HETRONIFLY (Serplulimab), India’s First Novel Immunotherapy for Advanced Small Cell Lung Cancer
AHMEDABAD, India, Aug. 5, 2025 /PRNewswire/ -- Intas Pharmaceuticals has launched HETRONIFLY™…
CGTMSE’s Silver Jubilee Celebration – Felicitation of Member Lending Institutions
MUMBAI, India, Aug. 1, 2025 /PRNewswire/ -- The Credit Guarantee Fund Trust for…
Commuting up Mount Snowdon: FLIT M2 Shows What a Single-Speed Folding Ebike Can Do
Thursday 31 July, 2025 FLIT, the Cambridge-based ebike developer, has released a…
Bybit’s $1M EthicHub Investment shifts 100 tons of LATAM coffee to higher-value markets
DUBAI, UAE, July 25, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
Zurich Kotak General Car Insurance: An Easy One-stop Solution For Car Owners
MUMBAI, India, June 26, 2025 /PRNewswire/ -- Zurich Kotak General Insurance's comprehensive car…
Alibaba.com Launches Trade Assurance in India to Empower SMEs
NEW DELHI, June 30, 2025 /PRNewswire/ -- Alibaba.com, a leading global business-to-business…
Novotech Earns Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class…
Kia Achieves Double Win at the 2025 Auto Express New Car Awards
Kia EV3 awarded ‘Small Company Car of the Year’ for its sharp…
From Desert Water Stop to Global Destination, Las Vegas Celebrates 120 Years of Iconic History and Reinvention
Orbi™Had the Honors of Blowing Out the Birthday Candles Throughout the DestinationLAS…
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
June 20, 2025 19:30 ET | Source: Structure Therapeutics Inc. SAN FRANCISCO,…
